Home NDC 0143-9651 MONTELUKAST
Product NDC 0143-9651
11-digit product format 001439651
Labeler code 0143
Product ID 0143-9651_88edb668-e5cc-4bdc-8cb0-622ebed87063
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name MONTELUKAST
Dosage form TABLET, CHEWABLE
Route ORAL
Labeler West ward Pharmaceutical Corp
Application ANDA203037
Marketing category ANDA
Marketing start 2014-12-01
Marketing end 0000-00-00
Substance MONTELUKAST SODIUM
Active strength 4 mg/1
Pharmacologic classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 88 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203037-001 MONTELUKAST SODIUM MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 A203037-002 MONTELUKAST SODIUM MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A203037-001 MONTELUKAST SODIUM EQ 4MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A203037-002 MONTELUKAST SODIUM EQ 5MG BASE TABLET, CHEWABLE / ORAL AB 2014-10-30 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0143-9651-09 MONTELUKAST 90 in 1 BOTTLE TABLET, CHEWABLE 90 3 0143-9651-10 MONTELUKAST 1000 in 1 BOTTLE TABLET, CHEWABLE 1000 3 0143-9651-30 MONTELUKAST 30 in 1 BOTTLE TABLET, CHEWABLE 30 3
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MONTELUKAST SODIUM ACTIVE INGREDIENT U1O3J18SFL MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 MONTELUKAST ACTIVE MOIETY MHM278SD3E MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 CHERRY INACTIVE INGREDIENT BUC5I9595W MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 MANNITOL INACTIVE INGREDIENT 3OWL53L36A MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0143-9651 MONTELUKAST TABLET, FILM COATED MONTELUKAST TABLET, CHEWABLE [WEST WARD PHARMACEUTICAL CORP] 3 Legacy NDC, 3 package rows 20151030_43b80e54-bd48-46f0-835e-b055e797a8c0.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 0143-9651-09 00143965109 90 in 1 BOTTLE Historical 0143-9651-10 00143965110 1000 in 1 BOTTLE Historical 0143-9651-30 00143965130 30 in 1 BOTTLE Historical